The article discusses recent research indicating that changes in the gut microbiome may offer a potential method for detecting Alzheimer’s disease (AD) at an early stage, even before the appearance of noticeable symptoms. Detecting AD in its early phases is crucial for effective treatment.
The study, published in Science Translational Medicine, focused on individuals in the initial stages of AD who showed no signs of cognitive decline. The researchers discovered that these individuals had a distinct composition of gut microbes compared to healthy individuals.